ArticleBlood2025

Duployez N, Largeaud L, Duchmann M, et al. Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study. Blood. 2022;140(7):756-768.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.